Recent Finacing
Recent Raise
SteroTherapeutics is a Philadelphia-based biopharmaceutical company developing metabolic therapies for NASH with a candidate ready for Phase I/II, pursuing orphan indications in Cushing's syndrome and rare breast cancer.
Focus Areas
Funding round
See the team members at SteroTherapeutics.
